Aster DM Healthcare and Faruk Medical City to develop healthcare services in Iraq
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
The capital expansion program commenced in June 2022 and is expected to complete in 2024
Company will invest approximately ¥16 billion to increase production capacity by approximately 70% to ensure a stable supply
Biopharma and CROs to benefit from simplified access to global research sites
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
Company is investing more than €100 million in the expansion of the Halle site
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry.
This agreement is in addition to the $92 million filling line expansion announced in November 2021
Subscribe To Our Newsletter & Stay Updated